Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

S1 guideline sweat gland carcinoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Same author

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Gut·2026

Same author

T cell engagers in autoimmune diseases.

Nature reviews. Immunology·2026

Same author

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Nature medicine·2026

Same author

Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trial.

Scientific reports·2026

Same author

Ectonucleotidases CD39 and CD73 expression levels are independent and inverse predictors of survival in muscle-invasive bladder cancer.

The journal of pathology. Clinical research·2026

Same journal

Enhancement of ferroptosis in escape variant tumor cells by IFN-γ derived from antigen-specific T cells controls tumor with heterogeneity.

Cancer immunology research·2026

Same journal

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

Cancer immunology research·2026

Same journal

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

Cancer immunology research·2026

Same journal

VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer.

Cancer immunology research·2026

Same journal

A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors.

Cancer immunology research·2026

Same journal

Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.

Cancer immunology research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 11, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor-Induced Colitis Compared with

Giulia Pesch¹, Ignazio Piseddu^2,3, Jan Gaertig³

¹Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany.

Cancer Immunology Research

|April 18, 2025

Summary

This summary is machine-generated.

Immune checkpoint inhibitor (ICI)-induced colitis (irColitis) differs from ulcerative colitis (UC). IrColitis shows T cell activation, while UC involves B cells and dendritic cells, suggesting distinct therapeutic targets for these conditions.

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Related Experiment Videos

Last Updated: May 11, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Area of Science:

Immunology
Gastroenterology
Oncology

Background:

Immune checkpoint inhibitor (ICI)-induced autoimmunity, particularly irColitis, is often treated like ulcerative colitis (UC) despite potential differences.
Limited understanding of irColitis pathogenesis hinders targeted therapy development.
Characterizing distinct immunophenotypes is crucial for developing specific treatments for irColitis.

Purpose of the Study:

To compare the local and systemic immunophenotypes of patients with irColitis and UC.
To identify key immunological differences that could inform distinct therapeutic strategies.

Main Methods:

Multicenter study comparing 20 irColitis patients, 15 UC patients, and 25 ICI-treated controls.
Analysis included gene expression of colonic mucosa and peripheral blood mononuclear cells (PBMC), serum proteomics, and flow cytometry of PBMCs.
Investigated local and systemic immune responses.

Main Results:

IrColitis mucosa showed upregulation of effector T cell and interferon signaling genes.
UC mucosa had higher expression of B cell and TNF signaling genes.
PBMC analysis revealed increased T cell activation, differentiation, and exhaustion markers in irColitis, contrasting with increased B cell and dendritic cell activation in UC.

Conclusions:

IrColitis is characterized by T cell-driven immune responses.
UC immunopathogenesis is more associated with B cell, dendritic cell activation, and TNF signaling.
These distinct immunophenotypes pave the way for developing more specific and effective treatments for irColitis.